Xentuzumab (Synonyms: BI 836845; Anti-Human IGF1 and IGF2 Recombinant Antibody) |
| Katalog-Nr.GC70151 |
Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) ist ein rekombinanter humanisierter monoklonaler Antikörper, der auf die IGF-Liganden IGF1 und IGF2 abzielt. Xentuzumab hemmt das Wachstumsförderungssignal von IGF1 und IGF2 und unterdrückt die Aktivierung von AKT.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1417158-65-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Xentuzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Xentuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *